HIGHLIGHTS
- who: Pancreatic Histotype Tumors et al. from the Department University and Emilia, Azienda Ospedaliera-Universitaria di Modena, Modena, Italy have published the Article: Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors, in the Journal: (JOURNAL) of August/17,/2017
- what: The very low incidence of these malignancies and the lack of knowledge concerning their biological features represent the main obstacles in the definition of a chemotherapy regimen that can be recommended in these patients.
- how: The following first-line chemotherapy regimens were used in the 16 evaluated patients who were evaluated gemcitabine plus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.